Search results for

Mark Green talks to NPR about what it's like leaving during a global health crisis — and what the future may hold for the agency.

Gilead Sciences, Inc., an American biopharmaceutical company, has published early results of a coronavirus drug trial on Wednesday. NPR science correspondents update on the latest coronavirus news.

Governments worldwide are tracing people with COVID-19 to stop the spread of the virus. NPR's Mary Louise Kelly talks with Massachusetts Gov. Charlie Baker about the state's contact tracing efforts.

NPR science and business correspondents talk about the protection of the workers — those working now, and those who will start soon, in a variety of industries.

NPR's Steve Inskeep talks to Illinois Gov. J.B. Pritzker about the president's claim that the federal government has the ultimate authority to determine when COVID-19 restrictions should be lifted.

COVID-19 has led to the suspension of many clinical studies of experimental treatments. About a quarter of the stopped trials involved new cancer treatments, an NPR analysis finds.

The Hulu series Mrs. Americafollows the epic battle between Phyllis Schlafly on one side and a battery of 1970s feminist activists on the other.

We spoke to students about to graduate into the workforce and posed their questions and anxieties to career counselors. Some advice: Be flexible, make it personal, network and look for bright spots.

As trillions of dollars begin to flow to bail out American industries, who's watching over it? We speak with Bharat Ramamurti, the first to be named to the Congressional Oversight Commission.

NPR politics, science and national correspondents relay the latest news on the response in the United States to the coronavirus epidemic.